The US Food and Drug Administration has approved Yeztugo (lenacapavir), an injectable HIV-1 capsid inhibitor, as preexposure prophylaxis (PrEP) to reduce the risk for sexually acquired HIV.

Lenacapavir is regarded as a significant step in improving prevention options for people at risk of HIV infection ...

HealthLink talked with a Seattle-based physician about why the newly approved drug could be a game-changer in preventing HIV.

Preparations are well underway for the fourth edition of the Dr Gasolo Long Walk to Success 2025 campaign. This initiative aims to amplify artists’ voices in the fight against drug and substance abuse ...

Deputy Prime Minister and Minister for Finance Professor Biman Prasad has delivered a powerful message to the nation’s youth, ...